Evidence of apoptosis in arrhythmogenic right ventricular dysplasia - PubMed (original) (raw)
. 1996 Oct 17;335(16):1190-6.
doi: 10.1056/NEJM199610173351604.
Affiliations
- PMID: 8815941
- DOI: 10.1056/NEJM199610173351604
Free article
Evidence of apoptosis in arrhythmogenic right ventricular dysplasia
Z Mallat et al. N Engl J Med. 1996.
Free article
Abstract
Background: Arrhythmogenic right ventricular dysplasia, a disorder that may lead to severe ventricular arrhythmias and sudden death, is characterized by the progressive replacement of myocardial cells by fat and fibrous tissue. We examined whether the loss of myocardial cells in this disease could result from cell death by apoptosis (programmed cell death).
Methods: Specimens obtained at autopsy from the right ventricular myocardium of eight patients with arrhythmogenic right ventricular dysplasia and four age-matched normal subjects were analyzed. To identify individual cells undergoing apoptosis, we performed in situ end-labeling of fragmented DNA on paraffin sections using biotinylated deoxyuridine triphosphate and the enzyme terminal deoxynucleotidyl transferase. We also examined the level of expression of CPP-32, a cysteine protease required for apoptotic cell death in mammalian cells, using immunohistochemical techniques.
Results: Apoptosis was detected in the right ventricular myocardium of six of the eight patients with arrhythmogenic right ventricular dysplasia and was absent in the controls. High levels of expression of CPP-32 were associated with positive in situ end-labeling of fragmented DNA.
Conclusions: These results indicate that apoptotic myocardial cell death occurs in arrhythmogenic right ventricular dysplasia and may contribute to the loss of myocardial cells in this disorder.
Comment in
- Apoptosis in the heart.
Colucci WS. Colucci WS. N Engl J Med. 1996 Oct 17;335(16):1224-6. doi: 10.1056/NEJM199610173351610. N Engl J Med. 1996. PMID: 8815947 No abstract available.
Similar articles
- In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy.
Valente M, Calabrese F, Thiene G, Angelini A, Basso C, Nava A, Rossi L. Valente M, et al. Am J Pathol. 1998 Feb;152(2):479-84. Am J Pathol. 1998. PMID: 9466574 Free PMC article. - Arrhythmogenic right ventricular dysplasia: from genetics to treatment.
Khan A, Mittal S, Sherrid MV. Khan A, et al. Anadolu Kardiyol Derg. 2009 Dec;9 Suppl 2:24-31. Anadolu Kardiyol Derg. 2009. PMID: 20089484 - Histological assessment of apoptotic cell death in cardiomyopathies.
Kavantzas NG, Lazaris AC, Agapitos EV, Nanas J, Davaris PS. Kavantzas NG, et al. Pathology. 2000 Aug;32(3):176-80. Pathology. 2000. PMID: 10968390 - [Significance of lymphoplasmocytic infiltration in arrhythmogenic right ventricular dysplasia. Apropos of 3 own cases and review of the literature].
Fontaliran F, Fontaine G, Brestescher C, Labrousse J, Vilde F. Fontaliran F, et al. Arch Mal Coeur Vaiss. 1995 Jul;88(7):1021-8. Arch Mal Coeur Vaiss. 1995. PMID: 7487318 Review. French. - [Arrhythmogenic right ventricular cardiomyopathy].
Wang QW, Liu L. Wang QW, et al. Fa Yi Xue Za Zhi. 2004;20(1):35-6, 39. Fa Yi Xue Za Zhi. 2004. PMID: 15150878 Review. Chinese.
Cited by
- Arrhythmogenic Right Ventricular Dysplasia in Neuromuscular Disorders.
Finsterer J, Stöllberger C. Finsterer J, et al. Clin Med Insights Cardiol. 2016 Oct 19;10:173-180. doi: 10.4137/CMC.S38446. eCollection 2016. Clin Med Insights Cardiol. 2016. PMID: 27790050 Free PMC article. Review. - Tissue-resident Sca1+ PDGFRα+ mesenchymal progenitors are the cellular source of fibrofatty infiltration in arrhythmogenic cardiomyopathy.
Paylor B, Fernandes J, McManus B, Rossi F. Paylor B, et al. F1000Res. 2013 Jun 19;2:141. doi: 10.12688/f1000research.2-141.v1. eCollection 2013. F1000Res. 2013. PMID: 24358871 Free PMC article. - Apoptosis in cardiovascular disease.
Davies MJ. Davies MJ. Heart. 1997 Jun;77(6):498-501. doi: 10.1136/hrt.77.6.498. Heart. 1997. PMID: 9227289 Free PMC article. Review. No abstract available. - Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome.
Akdis D, Saguner AM, Shah K, Wei C, Medeiros-Domingo A, von Eckardstein A, Lüscher TF, Brunckhorst C, Chen HSV, Duru F. Akdis D, et al. Eur Heart J. 2017 May 14;38(19):1498-1508. doi: 10.1093/eurheartj/ehx011. Eur Heart J. 2017. PMID: 28329361 Free PMC article. - Arrhythmogenic cardiomyopathy.
Pilichou K, Thiene G, Bauce B, Rigato I, Lazzarini E, Migliore F, Perazzolo Marra M, Rizzo S, Zorzi A, Daliento L, Corrado D, Basso C. Pilichou K, et al. Orphanet J Rare Dis. 2016 Apr 2;11:33. doi: 10.1186/s13023-016-0407-1. Orphanet J Rare Dis. 2016. PMID: 27038780 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials